Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) insider Nicholas Hollmeyer Lynton sold 6,464 shares of Cardlytics stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $3.67, for a total value of $23,722.88. Following the completion of the transaction, the insider now owns 91,771 shares of the company’s stock, valued at $336,799.57. The trade was a 6.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Cardlytics Trading Down 1.4 %
NASDAQ CDLX opened at $3.44 on Wednesday. The firm’s fifty day moving average price is $3.90 and its 200 day moving average price is $4.78. Cardlytics, Inc. has a 12 month low of $2.89 and a 12 month high of $20.52. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The company has a market capitalization of $174.83 million, a price-to-earnings ratio of -0.56 and a beta of 1.53.
Cardlytics (NASDAQ:CDLX – Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.18. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The company had revenue of $67.06 million for the quarter, compared to analyst estimates of $57.77 million. During the same quarter last year, the company posted ($0.26) earnings per share. The business’s quarterly revenue was down 15.1% compared to the same quarter last year. On average, sell-side analysts expect that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Cardlytics
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on CDLX shares. Evercore ISI started coverage on shares of Cardlytics in a research note on Friday, October 11th. They issued an “in-line” rating and a $4.00 price target for the company. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, November 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a report on Thursday, November 7th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics currently has a consensus rating of “Hold” and a consensus target price of $6.92.
Get Our Latest Stock Analysis on CDLX
About Cardlytics
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Featured Stories
- Five stocks we like better than Cardlytics
- Insider Buying Explained: What Investors Need to Know
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Short Selling – The Pros and Cons
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How is Compound Interest Calculated?
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.